2-methyl-2-[5-(morpholin-4-ylmethyl)-1-propan-2-ylindazol-3-yl]oxy-N-(2-pyridin-3-ylethyl)propanamide
C26H35N5O3 — CID 134810270
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-methyl-2-[5-(morpholin-4-ylmethyl)-1-propan-2-ylindazol-3-yl]oxy-N-(2-pyridin-3-ylethyl)propanamide
2-methyl-2-[5-(morpholin-4-ylmethyl)-1-propan-2-ylindazol-3-yl]oxy-N-(2-pyridin-3-ylethyl)propanamide (PubChem CID 134810270) has the molecular formula C26H35N5O3 and a molecular weight of 465.60 g/mol. Its IUPAC name is 2-methyl-2-[5-(morpholin-4-ylmethyl)-1-propan-2-ylindazol-3-yl]oxy-N-(2-pyridin-3-ylethyl)propanamide.
Molecular Properties
| Compound Name | 2-methyl-2-[5-(morpholin-4-ylmethyl)-1-propan-2-ylindazol-3-yl]oxy-N-(2-pyridin-3-ylethyl)propanamide |
|---|---|
| PubChem CID | 134810270 |
| Molecular Formula | C26H35N5O3 |
| Molecular Weight | 465.60 g/mol |
| Exact Mass | 465.27 |
| IUPAC Name | 2-methyl-2-[5-(morpholin-4-ylmethyl)-1-propan-2-ylindazol-3-yl]oxy-N-(2-pyridin-3-ylethyl)propanamide |
| SMILES | CC(C)n1nc(OC(C)(C)C(=O)NCCc2cccnc2)c2cc(CN3CCOCC3)ccc21 |
| InChI | InChI=1S/C26H35N5O3/c1-19(2)31-23-8-7-21(18-30-12-14-33-15-13-30)16-22(23)24(29-31)34-26(3,4)25(32)28-11-9-20-6-5-10-27-17-20/h5-8,10,16-17,19H,9,11-15,18H2,1-4H3,(H,28,32) |
| InChIKey | JIOJALAKDVWWEB-UHFFFAOYSA-N |
| XLogP | 3.36 |
| TPSA | 81.51 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 465.60 |
| LogP ≤ 5 | 3.36 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134810270 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.